Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

269
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
269
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Diagnostic Accuracy of AI-Assisted Focused Cardiac Ultrasound (FOCUS) in Primary Care.

Healthcare (Basel, Switzerland)·2025
Same author

Continuous Laser Versus Micropulse Laser in the Treatment of Central Serous Chorioretinopathy: A Retrospective Study.

Cureus·2024
Same author

Sociodemographic, cultural, linguistic, and test selection considerations for clinical neuropsychological assessment with Japanese and Japanese-American patients in the United States.

The Clinical neuropsychologist·2023
Same author

Corrigendum to Diversity and disparities in research studies and career trajectories in Psychiatry, Psychiatry Research, Volume 308, February 2022, 114333.

Psychiatry research·2022
Same author

Diversity and disparities in research studies and career trajectories in psychiatry.

Psychiatry research·2021
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

Desarrollo de Fármacos

Sayaka Machizawa1, Gila Barbati1, Madison Soleil DeCapo1

  • 1Signant Health, Blue Bell, PA, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
Resumen

Los errores en la administración y puntuación del Mini-Mental State Examination (MMSE) son comunes en los ensayos clínicos de la enfermedad de Alzheimer. La mejora de la capacitación de los evaluadores y la implementación del monitoreo de la calidad de los datos pueden mejorar la precisión de los datos.

Palabras clave:
ensayos clínicosenfermedad de AlzheimerMini-Mental State Examinationerrores de administraciónerrores de puntuacióncapacitación de evaluadoresmonitoreo de calidad de datos

Más Videos Relacionados

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

446

Videos de Experimentos Relacionados

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

446

Área de la Ciencia:

  • Neurología
  • Ensayos Clínicos
  • Evaluación Cognitiva

Sus antecedentes:

  • El Mini-Mental State Examination (MMSE) es una herramienta de evaluación cognitiva ampliamente utilizada en la investigación clínica.
  • A pesar de su prevalencia, se observan con frecuencia errores de administración y puntuación.
  • Estos errores surgen de directrices inconsistentes, experiencia del evaluador y aplicación de criterios.

Objetivo del estudio:

  • Identificar y explorar errores comunes de administración y puntuación en el MMSE.
  • Investigar estos errores entre los evaluadores del sitio en ensayos clínicos multinacionales de la enfermedad de Alzheimer.

Principales métodos:

  • Se realizaron revisiones centrales de las evaluaciones del MMSE de dos ensayos multinacionales de fase 3 de la enfermedad de Alzheimer.
  • Los revisores centrales capacitados analizaron el audio y los datos de las evaluaciones del MMSE, identificando errores utilizando indicadores predefinidos.
  • Las frecuencias de error se calcularon en función de la capacitación y los conjuntos de indicadores consistentes en todos los estudios.

Principales resultados:

  • Se revisaron más de 10 000 evaluaciones del MMSE, y aproximadamente el 27 % se marcaron por errores de administración y el 27 % por errores de puntuación.
  • Los errores más frecuentes incluyeron problemas de administración y puntuación en Orientación al Lugar, y errores de administración en Atención y Cálculo, Orientación Temporal y Escritura.
  • Se presentan las frecuencias detalladas de estos errores comunes.

Conclusiones:

  • El Mini-Mental State Examination (MMSE) presenta errores comunes de administración y puntuación en los ensayos clínicos.
  • Las prácticas no estandarizadas pueden introducir variabilidad en los datos, lo que podría afectar los resultados del estudio.
  • La implementación de un monitoreo sólido de la calidad de los datos, revisiones centrales y una capacitación mejorada de los evaluadores es crucial para mejorar la precisión y confiabilidad de los datos.